Centene's guidance for FY24 indicates a positive outlook on revenue, which could instill investor confidence and potentially lead to a short-term increase in stock price. The projected health benefits ratio is within industry norms, suggesting controlled costs relative to premiums, which is typically viewed favorably by investors.